- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00623662
Preoperative Glucose Infusion: a Novel Strategy to Improve Liver Function After Liver Resection
Metabolic Preconditioning Using Intravenous Dextrose: a Novel Strategy to Improve Hepatic Function After Liver Resection
The goal of the study is to determine whether intravenous glucose administration before liver resection preserves hepatic glycogen resulting in improved hepatic metabolic function after the operation.
We further investigate whether the benefit of avoiding preoperative fasting is more pronounced in patients undergoing more extensive liver resection.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Background. With a reported incidence of up to 70%, liver failure is the most frequent complication necessitating intensive care and prolonging hospital stay. Animal studies suggest that the glycogen content of the liver is a key regulator of liver function and that glycogen depletion, a mandatory consequence of preoperative fasting, is associated with poor clinical outcome.
The results of a pilot study demonstrate that metabolic preconditioning, i.e. the avoidance of preoperative fasting by intravenous administration of dextrose preserves hepatic glycogen and prevents hepatic dysfunction after liver resection. Liver function in this protocol was assessed by a score originally proposed by Schindl including serum concentrations of total bilirubin and lactate, prothrombin time and degree of encephalopathy. Due to alterations induced by anesthesia and surgery, e.g. blood loss necessitating transfusion, hypothermia, inflammatory responses and use of drugs with impact on hepatobiliary metabolism, liver function scores do not necessarily reflect functional integrity and metabolic capacity of the liver. In contrast, measuring the production of proteins that are exclusively synthetized by hepatocytes such as albumin allows a more specific and quantitative assessment of hepatic performance under perioperative conditions.
Hypothesis. We propose a randomized double-blinded study to test the hypothesis that, in patients scheduled for resection of liver cancer, metabolic preconditioning with intravenous dextrose preserves hepatic glycogen resulting in improved hepatic metabolic function postoperatively. We further hypothesize that the benefit of avoiding preoperative fasting is more pronounced in patients undergoing more extensive liver resection. Hepatic synthetic capacity will be assessed by measuring albumin synthesis using a stable isotope tracer technique.
Research plan. In order to test the validity of our assumptions, we will perform studies in patients scheduled for minor (study I; one or two liver segments, n=30) or major (study II; three or more liver segments, n=20) liver resection. In a double blinded fashion patients will be randomly assigned to receive either intravenous dextrose at 2 mg/kg/min or saline from 15:00 on the day before the operation until surgical skin incision. Metabolic processes at the organ level (liver, muscle), i.e. fractional synthesis rates of albumin, hepatic acute phase proteins (transthyretin (=prealbumin), fibrinogen, total plasma proteins) and muscle protein will be determined one day before and one day after the operation using primed-continuous infusions of L-[2H5]phenylalanine. Stable isotopes (L-[1-13C]leucine, [6,6-2H2]glucose) will be applied to assess dynamic changes in whole body protein and glucose metabolism before and after surgery, i.e. protein breakdown, amino acid oxidation, protein synthesis, glucose production and glucose uptake.
Significance. The demonstration that the preconditioning with dextrose preserves metabolic performance of the liver would have important implications for the clinical management of surgical patients with liver cancer. If preoperative dextrose administration attenuates hepatic dysfunction after liver resection, it will provide these patients with a readily available, safe and inexpensive therapy.
Studietype
Registrering (Forventet)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Quebec
-
Montreal, Quebec, Canada, H3A 1A1
- Rekruttering
- Royal Victoria Hospital, McGill University Health Centre
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- American Society of Anesthesiologists class ≤3
- liver resection (one or more liver segments) for primary or secondary malignancy
- ability to give informed consent
Exclusion Criteria:
- signs of severe malnutrition or obesity: body mass index (BMI) <20 or >30 kg.m-2, more than 10% involuntary body weight loss over the preceding six months, serum albumin <35 g.L-1
- chronic viral liver disease
- diabetes mellitus
- significant cardiorespiratory, renal and neurological disease
- musculoskeletal or neuromuscular disease
- severe anemia (hemoglobin <10 g.dL-1)
- history of severe sciatica or back surgery or other conditions which contraindicate the use of an epidural catheter
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Firemannsrom
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Aktiv komparator: 1
Glucose infusion.
|
Glucose infusion from 15:00 on the day before the operation until beginning of surgery.
|
Placebo komparator: 2
Normal saline infusion.
|
Normal saline infusion from 15:00 on the day before surgery until beginning of the operation.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Rate of albumin synthesis
Tidsramme: One day before and one day after surgery
|
One day before and one day after surgery
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Transthyretin synthesis, fibrinogen synthesis, whole body glucose and protein kinetics
Tidsramme: One day before and one day after surgery
|
One day before and one day after surgery
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Ralph Lattermann, MD PhD, Department of Anaesthesia, McGill University Health Centre
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- GEN-07-075
- CIHR 183635
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Leversvikt
-
Sisli Hamidiye Etfal Training and Research HospitalHar ikke rekruttert ennåErfaring, livTyrkia
-
Bournemouth UniversityDorset County Hospital NHS Foundation TrustFullførtErfaring, livStorbritannia
-
Universidad Complutense de MadridRekruttering
-
Swiss Federal Institute of TechnologyFullførtEldret | Uavhengig livSveits
-
Atılım UniversityHar ikke rekruttert ennåDOBBEL OPPGAVE | DEGLUTİTİON | KOGNITIV FUNKSJON | AKTIVITETER I DAGLIG LIV
-
Centre Hospitalier Universitaire DijonFullført
-
University of California, Los AngelesVA Greater Los Angeles Healthcare SystemTilbaketrukketVeteranfamilier | Familiekommunikasjon | Reintegrering av sivilt livForente stater
-
University of Erlangen-Nürnberg Medical SchoolGerman Federal Ministry of Education and Research; University of Erlangen-NürnbergFullførtUavhengig liv | Gamle og veldig gamle mennesker | FungererTyskland
-
University of ÉvoraUkjent
-
Dilek Yigit VuralFullførtSmerte | Fødsel, først | Erfaring, livTyrkia
Kliniske studier på Preoperative glucose infusion
-
University of NebraskaTilbaketrukket
-
Uppsala University HospitalRegion Stockholm; Capio Research FoundationFullført
-
Centre Jean PerrinRekruttering
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TilbaketrukketTilbakevendende plateepitelkarsinom i leppe- og munnhulen | Tilbakevendende plateepitelkarsinom i orofarynx | Tilbakevendende verrucous karsinom i munnhulen | Stage I plateepitelkarsinom i leppe- og munnhulen | Stage I plateepitelkarsinom i orofarynx | Stage I Verrucous karsinom i munnhulen | Stage... og andre forholdForente stater
-
University of AarhusUkjent
-
Pacific Diabetes TechnologiesRekruttering
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)FullførtTilbakevendende ikke-småcellet lungekreft | Fase 0 Ikke-småcellet lungekreft | Plateepitel lungekreft | Adenokarsinom i lungen | Storcellet lungekreftForente stater
-
University of ValenciaHospital Politècnic i Universitari la Fe de ValènciaFullført
-
University of VirginiaAmerican Cancer Society, Inc.; Integrated Translational Health Research...RekrutteringBlærekreft | Muskel-invasiv blærekarsinom | Ikke-muskelinvasiv blærekreftForente stater
-
Methodist University, North CarolinaCape Fear Orthopedics & Sports MedicineHar ikke rekruttert ennåDistal radiusbrudd | Tommelartrose | Flexorseneruptur